| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.84▼ | 3.82▼ | 3.82▼ | 3.79▲ | 3.48▲ |
| MA10 | 3.85▼ | 3.82▼ | 3.83▼ | 3.61▲ | 4.01▼ |
| MA20 | 3.83▼ | 3.82▼ | 3.82▼ | 3.43▲ | 4.79▼ |
| MA50 | 3.82▼ | 3.80▲ | 3.69▲ | 4.18▼ | 5.88▼ |
| MA100 | 3.83▼ | 3.67▲ | 3.45▲ | 4.97▼ | 6.77▼ |
| MA200 | 3.82▼ | 3.43▲ | 3.65▲ | 5.66▼ | 7.68▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.003▼ | -0.010▼ | 0.115▲ | -0.102▼ |
| RSI | 39.083▼ | 48.234▼ | 51.962▲ | 52.023▲ | 35.211▼ |
| STOCH | 27.030 | 34.646 | 32.897 | 91.907▲ | 15.310▼ |
| WILL %R | -100.000▼ | -84.211▼ | -68.085 | -17.526▲ | -73.154 |
| CCI | -182.663▼ | -21.921 | 14.413 | 103.736▲ | -57.523 |
| ▲ GAP | $AXL Open Gap Up %2 | Set Alert |
|
Wednesday, April 30, 2025 05:00 AM
BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 3.90 | 3.97 | 3.77 | 3.80 | 4,179,800 |
| 30/04/25 | 3.76 | 3.87 | 3.72 | 3.82 | 2,499,700 |
| 29/04/25 | 3.73 | 3.865 | 3.68 | 3.835 | 2,291,046 |
| 28/04/25 | 3.75 | 3.85 | 3.72 | 3.76 | 1,848,800 |
| 25/04/25 | 3.64 | 3.74 | 3.61 | 3.73 | 2,528,200 |
| 24/04/25 | 3.39 | 3.71 | 3.38 | 3.70 | 3,525,000 |
| 23/04/25 | 3.47 | 3.55 | 3.37 | 3.39 | 2,512,300 |
| 22/04/25 | 3.38 | 3.42 | 3.28 | 3.37 | 2,362,900 |
| 21/04/25 | 3.29 | 3.35 | 3.20 | 3.33 | 2,392,400 |
| 17/04/25 | 3.24 | 3.36 | 3.23 | 3.34 | 2,204,616 |
|
|
||||
|
|
||||
|
|